Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseases

This publication has 192 references indexed in Scilit:

• Parkin exerts the tumor‐suppressive effect through targeting mitochondria
  Medicinal Research Reviews, 2023
• The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
  Clinical and Translational Medicine, 2023
• The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1
  Hepatology, 2021
• Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD
  Hepatology, 2021
• Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD
  Hepatology, 2021
• Speckle‐type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase
  The Prostate, 2019
• Hepatic PPARα function is controlled by polyubiquitination and proteasome‐mediated degradation through the coordinated actions of PAQR3 and HUWE1
  Hepatology, 2018
• CD2‐Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling
  Hepatology, 2018
• The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
  Hepatology, 2016
• Acetyl‐coenzyme A carboxylase alpha promotion of glucose‐mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients
  Hepatology, 2015